ATOSSA THERAPEUTICS
Live / Applied — First extension granted (statement of use) (as of 16 Jan 2026)
What this means for you
Not registered yet, but its 15 Nov 2024 filing date beats anything filed after it. If it registers, the owner can stop confusingly similar uses in the classes it covers.
Record
- Serial number
- 98855971
- Mark type
- Design + words
- Filed
- 15 Nov 2024
- Published for opposition
- 17 Jun 2025
- Attorney of record
- Margaret McHugh
Goods and services
- Class 005 — Pharmaceuticals: Biological preparations for the treatment of breast cancer; Pharmaceutical preparations for the treatment of breast cancer; Medicinal preparations for the treatment of breast cancer
- Class 044 — Medical, beauty and agricultural services: Medical diagnosis and treatment of breast cancer
Owner
- Atossa Therapeutics, Inc., Seattle, WA, US
- Atossa Therapeutics, Inc., Seattle, WA, US
Prosecution history
- 17 Jan 2026 — NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
- 16 Jan 2026 — SOU EXTENSION 1 GRANTED
- 16 Jan 2026 — SOU EXTENSION 1 FILED
- 16 Jan 2026 — SOU TEAS EXTENSION RECEIVED
- 12 Aug 2025 — NOA E-MAILED - SOU REQUIRED FROM APPLICANT
- 17 Jun 2025 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Jun 2025 — PUBLISHED FOR OPPOSITION
- 11 Jun 2025 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 14 May 2025 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 14 May 2025 — EXAMINER'S AMENDMENT ENTERED
- 14 May 2025 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED
- 14 May 2025 — EXAMINERS AMENDMENT E-MAILED
- 14 May 2025 — EXAMINERS AMENDMENT -WRITTEN
- 12 May 2025 — ASSIGNED TO EXAMINER
- 08 May 2025 — NOTICE OF DESIGN SEARCH CODE E-MAILED